Lattice Biologics (TSX-V: LBL) (OTCBB: BLVKF) announced an increase in the size of its non-brokered private placement, from $750,000 to $1.5M in response to high investor demand. As a result, the funding […]
A Unique Roadblock for Pfizer’s Osteoarthritis Drug
We’ve heard of drugs underperforming in clinical trials, but is it possible for a drug to over-perform?
